We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Parkinson's Disease Linked to Malfunctions in Mitochondrial Fission and Fusion

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Image: Two mitochondria from mammalian tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
Image: Two mitochondria from mammalian tissue displaying their matrix and membranes as shown by electron microscopy (Photo courtesy of Wikimedia Commons).
Neurodegenerative diseases researchers in the United Kingdom have found that development of Parkinson's disease (PD) is linked to malfunctions in the processes that regulate mitochondrial fission and fusion.

Mitochondrial dysfunction has been reported in both the familial and sporadic forms of PD. Mitochondria are constantly fusing and dividing with each other, forming large, reticular networks. To study the molecular regulators of these processes, investigators at Plymouth University (United Kingdom) used two complementary mouse models of mitochondrial impairments as seen in PD: the PTEN-induced putative kinase-1 deletion (PINK1−/−) and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse models.

They reported in the November 5, 2014, online edition of the journal Nature Communications that blocking the action of the mitochondrial fission protein GTPase dynamin-related protein-1 (Drp1) using either gene-therapy or a chemical approach reduced both cell death and deficits in dopamine release, which effectively reversed PD progression in both models.

Drp1 is a member of the Dynamin enzyme family of large GTPases. Drp1 controls the final part of mitochondrial fission, pinching off the membrane stalk between two forming daughter mitochondria. Several studies have indicated that Drp1 is essential for proper embryonic development, and that in humans, loss of Drp1 function affects brain development and is also associated with early mortality.

Senior author Dr. Kim Tieu, associate professor of clinical neurobiology at Plymouth University, said, "Our findings show exciting potential for an effective treatment for PD and pave the way for future in-depth studies in this field. It is worth noting that other researchers are also targeting this mitochondrial fission/fusion pathway as potential treatments for other neurological diseases such as Alzheimer's disease, Huntington's disease and Amyotrophic Lateral Sclerosis."

Related Links:

Plymouth University


New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.